A critical assessment of the current status of non-erosive reflux disease

Digestion

Volumn 78, Issue SUPPL. 1, 2008, Pages 46-54

  Armstrong, David ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Erosive esophagitis; Esophageal manifestations; Gastroesophageal reflux disease; Non erosive reflux disease definition

Indexed keywords

ANTACID AGENT; PROTON PUMP INHIBITOR;

CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HEARTBURN; MEDICAL RESEARCH; NON EROSIVE REFLUX DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SENSITIVITY AND SPECIFICITY; STOMACH EROSION; TREATMENT RESPONSE;

ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 53349095608     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151255     Document Type: Conference Paper

References (29)

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, the Global Consensus Group: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920.
2. Fass R, Ofman JJ: Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002;97:1901-1909.
3. Armstrong D, Marshall JK, Chiba N, et al: Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol 2005;19:15-35.
4. Lundell LR, Dent J, Bennett JR, et al: Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180.
5. Armstrong D, Bennett J, Blum A, et al: The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85-92.
6. Bytzer P, Havelund T, Möller Hansen J: Interobserver variation in the endoscopic diagnosis of reflux esophagitis. Scand J Gastroenterol 1993;28:119-125.
7. Miwa H, Yokoyama T, Hori K, et al: Interobserver agreement in endoscopic evaluation of reflux esophagitis using a modified Los Angeles classification incorporating grades N and M: a validation study in a cohort of Japanese endoscopists. Dis Esoph 2008;21:355-363.
8. Armstrong D, Barkun AN, Grace E, Schmuck ML, Shannon S: Do you see what I see? Interobserver agreement for upper GI endoscopy video clips in 30 endoscopists (abstract). Gastroenterology 2002;122:A471-A472.
9. Bytzer P: Information bias in endoscopic assessment. Am J Gastroenterol 2007;102:1585-1587.
10. Armstrong D, Veldhuyzen van Zanten SJO, Barkun AN, et al: Heartburn-Dominant, Uninvestigated Dyspepsia: a Comparison of 'PPI-Start' and 'H2-RA-Start' Management Strategies in Primary Care - the CADET-HR Study. Aliment Pharmacol Ther 2005;21:1189-1202.
11. Caos A, Breiter J, Perdomo C, Barth J: Long-term prevention of erosive or ulcerative gastrooesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States. Aliment Pharmacol Ther 2005;22:193-202.
12. Donnellan C, Sharma N, Preston C, Moayyedi P: Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2004;4:CD003245.
13. Farup P, Hovde O, Torp R, et al: Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-esophageal reflux pattern. Scand J Gastroenterol 1999;34:575-579.
14. Vakil N, Katz P, Traxler B, et al: Resolution of epigastric pain accompanies resolution of heartburn in endoscopy-negative GERD (abstract). Gastroenterology 2003;124:A542.
15. Armstrong D: Symptom assessment: methods and content. J Clin Gastroenterol 2007;41:S184-S192.
16. Bardhan KD, Stanghellini V, Armstrong D, et al: Evaluation of GERD symptoms during therapy. I. Development of the new GERD questionnaire ReQuest™. Digestion 2004;69:229-237.
17. Bardhan KD, Stanghellini V, Armstrong D, et al: International validation of ReQuest™ in patients with endoscopy negative gastrooesophageal reflux disease. Aliment Pharmacol Ther 2004;20:891-898.
18. Galmiche J, Clouse R, Bálint A, Cook I, Kahrilas P, Paterson W, Smout A: Functional esophageal disorders. Gastroenterology 2006;130:1459-1465.
19. Ronkainen J, Aro P, Storskrubb T, et al: High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275-285.
20. Solcia E, Villani L, Luinetti O, et al: Altered intercellular glycoconjugates and dilated intercellular spaces of esophageal epithelium in reflux disease. Virchows Arch 2000;436:207-216.
21. Caviglia R, Ribolsi M, Maggiano N, et al: Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol 2005;100:543-548.
22. Ismail-Beigi F, Horton PF, Pope CE: Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-174.
23. Hirano I, Richter JE, the Practice Parameters Committee of the American College of Gastroenterology: ACG Practice Guidelines: esophageal reflux testing. Am J Gastroenterol 2007;102:668-685.
24. Kahrilas PJ, Quigley EMM: Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996;110:1982-1996.
25. Weusten BLAM, Roelofs JMM, Akkermans LMA, Van Berge-Henegouwen GP, Smout AJPM: The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994;107:1741-1745.
26. Carlsson R, Fandriks L, Jonsson C, et al: Is the esophageal squamous epithelial barrier function impaired in patients with gastroesophageal reflux disease? Scand J Gastroenterol 1999;34:454-458.
27. Bardhan KD, Royston C, Nayyar AK: Reflux rising! An essay on witnessing a disease in evolution. Dig Liv Dis 2006;38:163-168.
28. Armstrong D: Systematic review: persistence and severity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2008;28:841-853.
29. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS: Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333-338.